AEK-3212939-5/31/1

Novartis Pharma AG — FEI 3002807772

Refusal Details

Date
May 3, 2023
Country
Switzerland
Product Category
Drugs and Biologics
Product Code
66VIY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75